1. Home
  2. ASIC vs ODTX Comparison

ASIC vs ODTX Comparison

Compare ASIC & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ategrity Specialty Insurance Company Holdings

ASIC

Ategrity Specialty Insurance Company Holdings

SELL

Current Price

$24.36

Market Cap

1.3B

Sector

Finance

ML Signal

SELL

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

SELL

Current Price

$19.34

Market Cap

1.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ASIC
ODTX
Founded
2018
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2025
2025

Fundamental Metrics

Financial Performance
Metric
ASIC
ODTX
Price
$24.36
$19.34
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$28.40
★ $34.67
AVG Volume (30 Days)
73.7K
★ 287.4K
Earning Date
10-21-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 23.44
N/A
EPS
★ 1.47
N/A
Revenue
★ $424,339,000.00
N/A
Revenue This Year
$24.89
N/A
Revenue Next Year
$22.34
N/A
P/E Ratio
$16.69
★ N/A
Revenue Growth
★ 23.41
N/A
52 Week Low
$16.73
$15.10
52 Week High
$29.00
$29.05

Technical Indicators

Market Signals
Indicator
ASIC
ODTX
Relative Strength Index (RSI) 45.26 48.61
Support Level $23.36 $18.87
Resistance Level $25.62 $19.60
Average True Range (ATR) 0.84 1.78
MACD 0.08 0.09
Stochastic Oscillator 62.35 33.45

Price Performance

Historical Comparison
ASIC
ODTX

About ASIC Ategrity Specialty Insurance Company Holdings

Ategrity Specialty Insurance Co Holdings is a specialty property and casualty insurance holding company focused on the excess and surplus market for small to medium-sized businesses (SMBs) across the United States. Operating through its subsidiaries, the company underwrites small and medium-sized commercial risks across selected industry verticals, including Retail, Real Estate, Hospitality, and Construction. Its operating model uses a technology-driven method to standardize, simplify, and, where appropriate, automate these transactions. The group distributes its products through licensed surplus lines brokers and wholesale agents.

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Share on Social Networks: